Fresenius Medical Care
Fresenius Medical Care
FME
XETR
44.56
EUR
0.13%
About
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products.
Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers..
Financials Amount (in millions)
Income statement
Balance sheet
Cash flow
Ratios
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 252.9K |
| Three Month Average Volume | 7.8M |
| High Low | |
| Fifty-Two Week High | 44.89 EUR |
| Fifty-Two Week Low | 30.16 EUR |
| Fifty-Two Week High Date | 04 Sep 2023 |
| Fifty-Two Week Low Date | 11 Oct 2023 |
| Price and Volume | |
| Current Price | 34.86 EUR |
| Beta | 1 |
| Relative Price Change | |
| Four Week Relative Price Change | -5.83% |
| Thirteen Week Relative Price Change | -12.95% |
| Twenty-Six Week Relative Price Change | -8.23% |
| Fifty-Two Week Relative Price Change | -34.00% |
| Year-to-Date Relative Price Change | -18.63% |
| Price Change | |
| One Day Price Change | 0.32% |
| Thirteen Week Price Change | -11.03% |
| Twenty-Six Week Price Change | -2.16% |
| Five Day Price Change | 0.96% |
| Fifty-Two Week Price Change | -21.75% |
| Year-to-Date Price Change | -8.17% |
| Month-to-Date Price Change | -2.84% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | 46.42003 EUR |
| Book Value Per Share (Most Recent Quarter) | 47.48113 EUR |
| Tangible Book Value Per Share (Last Fiscal Year) | -8.15257 EUR |
| Tangible Book Value Per Share (Most Recent Quarter) | -7.60097 EUR |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | 12.0688 EUR |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 66.30104 EUR |
| Revenue Per Share (Trailing Twelve Months) | 66.16971 EUR |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | 1.19 EUR |
| Dividend Per Share (Trailing Twelve Months) | 1.19 EUR |
| Dividend Per Share (5 Year) | 1.24 EUR |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | 1.70066 EUR |
| Excluding Extraordinary Items (Trailing Twelve Months) | 1.80722 EUR |
| Normalized (Last Fiscal Year) | 2.91476 EUR |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | 1.70066 EUR |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | 1.80722 EUR |
| Including Extraordinary Items (Last Fiscal Year) | 1.70066 EUR |
| Including Extraordinary Items (Trailing Twelve Months) | 1.80722 EUR |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 5.47293 EUR |
| Cash Per Share (Most Recent Quarter) | 4.80045 EUR |
| Cash Flow Per Share (Last Fiscal Year) | 7.98509 EUR |
| Cash Flow Per Share (Trailing Twelve Months) | 8.66302 EUR |
| Free Cash Flow Per Share (Trailing Twelve Months) | 4.57192 EUR |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | 8 |
| Cash Flow Revenue (Trailing Twelve Months) | 7 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | 5.54% |
| Pretax Margin (Last Fiscal Year) | 5.31% |
| Pretax Margin (5 Year) | 8.28% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 25.32% |
| Gross Margin (Trailing Twelve Months) | 25.33% |
| Gross Margin (5 Year) | 27.80% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | 7.04% |
| Operating Margin (Trailing Twelve Months) | 7.33% |
| Operating Margin (5 Year) | 10.14% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | 3.77% |
| Net Profit Margin (Trailing Twelve Months) | 3.93% |
| Net Profit Margin (5 Year) | 6.23% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | 3.91% |
| Tangible Book Value (5 Year) | -99,999.99% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | 21.72% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | -1.22% |
| Revenue Growth (3 Year) | 3.29% |
| Revenue Change (Trailing Twelve Months) | -1.06% |
| Revenue Per Share Growth | 4.25% |
| Revenue Growth (5 Year) | 2.89% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | -9.05% |
| Total Debt (5 Year) | 9.42% |
| Dividends | |
| Dividend Growth (3 Year) | -3.88% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | 33.25% |
| EPS Change (Trailing Twelve Months) | -10.97% |
| EPS Growth (3 Year) | -23.40% |
| EPS Growth (5 Year) | -24.55% |
| EBITDA | |
| EBITDA (5 Year) | 2.27% |
| EBITDA (5 Year Interim) | 1.83% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -22.48% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | -100,000 |
| Price to Tangible Book (Most Recent Quarter) | -100,000 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | 6 |
| Price to Free Cash Per Share (Trailing Twelve Months) | 8 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | 10.3B |
| Net Debt (Last Fiscal Year) | 10.4B |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 1 |
| Price to Sales (Trailing Twelve Months) | 1 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | 19 |
| PE Normalized (Last Fiscal Year) | 12 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | 20 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | 27 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | 11 |
| PE Including Extraordinary Items (Trailing Twelve Months) | 19 |
| Dividends | |
| Dividend Yield (5 Year) | 2.39% |
| Dividend Yield | 3.41% |
| Current Dividend Yield | 3.41% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | 1 |
| Price to Book (Most Recent Quarter) | 1 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 77 |
| Long Term Debt to Equity (Most Recent Quarter) | 74 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | 69.94% |
| Payout Ratio (Trailing Twelve Months) | 65.82% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | 1 |
| Quick Ratio (Most Recent Quarter) | 1 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | 17 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | 12 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 1 |
| Current Ratio (Most Recent Quarter) | 1 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | 1.6B |
| Free Cash Flow (Trailing Twelve Months) | 1.3B |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | 7 |
| Net Interest Coverage (Trailing Twelve Months) | 6 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 88 |
| Total Debt to Equity (Most Recent Quarter) | 84 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | 2.10% |
| Return on Assets (Trailing Twelve Months) | 2.21% |
| Return on Assets (5 Year) | 3.47% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | 3.61% |
| Return on Equity (Trailing Twelve Months) | 3.86% |
| Return on Equity (5 Year) | 7.20% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | 2.69% |
| Return on Investment (Trailing Twelve Months) | 2.84% |
| Return on Investment (5 Year) | 4.56% |